Stephen Biggar
Presidente presso ACADIA PHARMACEUTICALS INC.
Patrimonio netto: 95 050 $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stephen Davis | M | 63 | 13 anni | |
| Sanj Patel | M | 54 | 16 anni | |
| Felix Baker | M | 55 | 24 anni | |
| Gavin MacBeath | M | 54 | 6 anni | |
| Barry Quart | M | 67 | 12 anni | |
| Eben Tessari | M | 42 | 10 anni | |
| Thomas Malley | M | 55 | 18 anni | |
| Michael Megna | M | 53 | 6 anni | |
| Mark Ragosa | M | 50 | 6 anni | |
| Jon Stonehouse | M | 63 | 17 anni | |
| George Abercrombie | M | 69 | 13 anni | |
| Julian Baker | M | 57 | 9 anni | |
| Bob Mischler | M | - | 9 anni | |
| Tracey McCain | F | 56 | 6 anni | |
| Peter Zandstra | M | - |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 6 anni |
| R. Woods | M | 56 | 1 anni | |
| Melissa Manno | F | - | 9 anni | |
| Leiden Dworak | M | - | 2 anni | |
| Rachel Frank | F | - | - | |
| Zoran Zdraveski | M | 54 | 3 anni | |
| Albert Kildani | M | - | 1 anni | |
| Elizabeth Garofalo | M | 66 | 4 anni | |
| Brendan Teehan | M | 56 | 6 anni | |
| Gabriela Gruia | M | 67 | 3 anni | |
| Julie Fisher | F | - | 6 anni | |
| Madelyn Zeylikman | F | - | 4 anni | |
| Mark Schneyer | M | 50 | 4 anni | |
| Katina Dorton | F | 66 | 3 anni | |
| Barbara Klencke | M | 66 | 1 anni | |
| William P. Sheridan | M | 69 | 16 anni | |
| Jennifer J. Rhodes | F | 53 | - | |
| Don Soland | M | 65 | 9 anni | |
| Kim Popovits | F | 65 | 6 anni | |
| G. Cole | M | 68 | 4 anni | |
| Laura Brege | F | 66 | 16 anni | |
| David Main | M | 59 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 4 anni |
| Richard Levy | M | 66 | 5 anni | |
| Alane Barnes | F | 58 | 18 anni | |
| Katherine Bishop | M | 58 | 3 anni | |
| Edmund Harrigan | M | 71 | 9 anni | |
| James Daly | M | 62 | 8 anni | |
| Kazenelson Deb | F | - | - | |
| Chad Morin | M | - | 4 anni | |
| Rob Ackles | M | - | 10 anni | |
| Kimberly Manhard | F | 64 | - | |
| Benir Ruano | M | - | 2 anni | |
| Ray Lockard | M | - | 1 anni | |
| Shrikanta Chattopadhya | M | - | - | |
| James Kihara | M | - | 4 anni | |
| Adora Ndu | M | 43 | 2 anni | |
| Ross Moat | M | 43 | 5 anni | |
| Ann Hargraves | F | - | 4 anni | |
| Parag V. Meswani | M | - | 2 anni | |
| Martina Struck | M | - | 6 anni | |
| Heather Savelle | F | - | 3 anni | |
| Jason Amello | M | 55 | - | |
| Raf Hofstein | M | 75 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
| John Paolini | M | 59 | 8 anni | |
| Timothy Penner | M | 68 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
| Justin McCue | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 95 | 95.96% |
| Canada | 4 | 4.04% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Stephen Biggar
- Contatti personali
